Evaluation of Haematological Parameters and Lymphocyte Monocyte Ratio as a Prognostic Marker in Diffuse Large B-cell Lymphoma and T Cell Lymphoma Patients- An Observational Study

Background: The present study is a retrospective observational analysis of patients diagnosed with DLBCL and T cell lymphoma during the period January 2011 to December 2015 at Malabar Cancer Centre, Thalassery. Several studies have shown that ALC LMR can be used as prognostic indicators for diagnosis, treatment survival in DLBCL. But there were very few done on correlation these parameters lymphoma. So we analysed influence haematological both lymphomas. primary objective was correlate predictors Methods: We total cases 108 25 determine changes including WBC count, Platelet Hb, HCT, lymphocyte monocyte ALC, AMC ratio diffuse large B lymphomas before after chemotherapy. Results: results showed significant decrease (p˂ 0.05) blood platelet counts chemotherapy female decreased (0.69 ± 0.36 0.53 0.31; p-value = 0.023) this highly significant. also increased (3.47 3.05 5.22 4.34; 0.048) Conclusion: Haematological marker predicting extent disease progression effectiveness adopted.